Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Johnson & Johnson

Investors looking for dividend income often compare BlackRock’s ($BLK) iShares Core Dividend Growth ETF ($DGRO) and iShares Core High Dividend ETF ...

DGRO vs. HDV: Which BlackRock iShares Dividend ETF Pays More Income?

The U.S.-Iran conflict and AI bubble concerns are weighing on global stock markets. Investors looking for attractive opportunities amid the ongoing...

Best ETFs to Invest In, According to AI Analyst, 3/4/2026

Insiders have been trading these 5 stocks: (($BA)), (($WMT)), (($KO)), (($F)) and (($JNJ)). Here is a breakdown of their recent trades and their va...

Boeing, Walmart, Coca-Cola, Ford, J&J: Insider Moves Exposed

Traders will find the top stock market stories for Monday in our daily wrap-up.


Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!

German drugmaker Bayer ($BAYRY) for the second time this year came at Johnson & Johnson ($JNJ) with a new lawsuit. However, the American health gia...

“J&J’s Claims of Superiority… Are False”: Johnson & Johnson Stock Rises despite Bayer Lawsuit

U.S. stocks ended the week higher, even as sharp moves in individual names kept traders on edge. The S&P 500 (SPX) rose 0.69%, the Nasdaq 100 (NDX)...

The Week That Was, The Week Ahead: Macro and Markets, Feb. 22

Insiders have been trading these 5 stocks: (($MSFT)), (($DIS)), (($BA)), (($JNJ)) and (($JPM)). Here is a breakdown of their recent trades and thei...

Microsoft, Disney, Boeing, J&J, JPMorgan Insider Shock

Healthcare giant Johnson & Johnson ($JNJ) is gearing up to sell its orthopedics unit, with several large buyout firms already showing interest, Blo...

Johnson & Johnson (JNJ) Gears Up for a Potential $20B Sale of Orthopedics Unit

Traders looking for the latest stock market stories will find them in the TipRanks daily wrap-up.


Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!

Johnson & Johnson’s ($JNJ) shares rose fractionally on Wednesday morning after the American pharma giant rolled out plans to pump over $1 billion i...

Johnson & Johnson Stock (JNJ) Rises on $1B Pennsylvania Plant to Expand U.S. Manufacturing

Walmart ($WMT) is set to release its Q4 earnings this week. It may not be of huge importance to those queues of people grabbing groceries and snapp...

Crowd Turns on Walmart Ahead of Q4 Earnings

There are many sectors within the health category. 


IHI, IHE, ARKG: Specialty Healthcare ETFs Can Help Boost a Portfolio

As market volatility and interest-rate uncertainty linger, many investors are shifting their focus from chasing returns to protecting capital. Vang...

VTI vs. VGSH vs. VFMV: Which Vanguard ETF Is the Safest Bet in Today’s Market?

For many investors, exchange-traded funds (ETFs) are anything but straightforward, with a confusing array of formats, themes, and ticker symbols th...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	JNJ	$240.40	+0.32%	7.18M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	JNJ	$240.40	+0.3%	7.18M
3
4
5
6

JNJ

JNJ

Get Johnson & Johnson Data in Excel

Get Johnson & Johnson Data in Excel